# Protalix BioTherapeutics, Inc.: Form 8-K/A, filed Mar 23, 2011

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K/A
- Filed: 2011-03-23
- Accepted by EDGAR: Mar 23, 2011, 16:05 ET
- Period: 2011-03-17
- Accession: 0000950123-11-028238
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000095012311028238/y04677e8vkza.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000095012311028238/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000095012311028238/y04677e8vkza.htm

Filed Mar 23, 2011.
Source: SEC EDGAR, the filing index for accession 0000950123-11-028238. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
